Wednesday, the FDA granted accelerated approval to Eli Lilly And Co’s (NYSE:LLY) selpercatinib (Retevmo) for pediatric ...

The U.S. FDA has granted accelerated approval to Eli Lilly's Retevmo (Selpercatinib) for pediatric patients two and older for ...

Eli Lilly said on Thursday that its once-weekly insulin efsitora met the main goals in two late-stage trials evaluating it in ...

Eli Lilly shares were on pace for a record closing high Tuesday after the drugmaker released data from a late-stage Crohn’s ...

China gave the greenlight to Eli Lilly & Co.’s blockbuster drug tirzepatide for use in treating diabetes, a move that will ...

Eli Lilly said on Tuesday its diabetes drug tirzepatide has received approval from Chinese regulators, setting up ...

The company said the site footprint will not expand, but the company will fill in the property with more buildings and ...

The obesity market has garnered much interest lately, ever since Novo Nordisk (NYSE: NVO) received FDA approval for its ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Tirzepatide, a novel dual agonist at both the GLP-1 and the glucose-dependent insulinotropic polypeptide (GIP) receptor, was ...

Over 40 people have been killed, with dozens more injured, after an Israeli strike on the Tel Al-Sultan neighbourhood in western Rafah, Gaza. Video: Reuters ...

If you'd invested $10,000 in Eli Lilly stock five years ago, you would have $65,900 today. That's a gain worthy of a top ...